UiPath (PATH) just checked several key boxes for investors at once, moving from GAAP losses to profit while accelerating revenue growth and doubling down on its agentic AI and automation platform strategy.
See our latest analysis for UiPath.
Even after a sharp post earnings jump, UiPath’s recent 22% one month share price return and roughly 53% three month share price return suggest momentum is building as investors digest new AI partnerships, the Peak acquisition, and ongoing buybacks on top of its move to profitability.
If UiPath’s run has you rethinking your tech exposure, this might be a good moment to explore other high growth tech and AI names using high growth tech and AI stocks for fresh ideas.
With the stock now trading slightly above the average analyst target but still at a modest intrinsic discount, investors face a key question: is UiPath mispriced on the upside, or is the market underestimating its next leg of AI driven growth?
With UiPath last closing at 17.42 dollars against a narrative fair value of about 15.93 dollars, the story leans toward optimism on future AI monetization.
Strategic partnerships and platform updates are viewed as incremental drivers that could support better revenue growth and operating leverage as customers standardize on UiPath for AI infused workflows. Recent sector checks suggesting more resilient software demand, particularly around AI enabled solutions, support the view that UiPath’s addressable market and long term growth runway remain intact.
Curious what kind of revenue climb, margin lift, and future earnings multiple are baked into that valuation jump, and how long the runway really stretches? Dive in to see which specific levers this narrative is betting on to justify paying up today for tomorrow’s automation leader.
Result: Fair Value of $15.93 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, deal delays from geopolitical uncertainty and FX headwinds could easily derail revenue momentum. This may test investors’ conviction in the AI automation growth story.
Find out about the key risks to this UiPath narrative.
On earnings, UiPath looks pricey at about 40.6 times profit versus 32.9 times for the US software group and a fair ratio of roughly 14.6 times, yet still cheaper than peer averages near 62.5 times. Is that middle ground a margin of safety or a valuation trap if growth wobbles?
See what the numbers say about this price — find out in our valuation breakdown.
